CN210811025U - A ventriculo-peritoneal cerebrospinal fluid shunt flow detection device - Google Patents
A ventriculo-peritoneal cerebrospinal fluid shunt flow detection device Download PDFInfo
- Publication number
- CN210811025U CN210811025U CN201921350762.9U CN201921350762U CN210811025U CN 210811025 U CN210811025 U CN 210811025U CN 201921350762 U CN201921350762 U CN 201921350762U CN 210811025 U CN210811025 U CN 210811025U
- Authority
- CN
- China
- Prior art keywords
- shunt
- storage bag
- liquid
- cerebrospinal fluid
- pipe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000001175 cerebrospinal fluid Anatomy 0.000 title claims abstract description 39
- 238000001514 detection method Methods 0.000 title claims abstract description 31
- 239000007788 liquid Substances 0.000 claims abstract description 123
- 238000003860 storage Methods 0.000 claims abstract description 64
- 239000012567 medical material Substances 0.000 claims abstract description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 239000010931 gold Substances 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 239000011133 lead Substances 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims 3
- 239000000463 material Substances 0.000 abstract description 9
- 208000035965 Postoperative Complications Diseases 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 238000003745 diagnosis Methods 0.000 abstract description 3
- NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 27
- 229940084026 sodium valproate Drugs 0.000 description 27
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 27
- 239000000243 solution Substances 0.000 description 15
- 210000000683 abdominal cavity Anatomy 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000002627 tracheal intubation Methods 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010022773 Intracranial pressure increased Diseases 0.000 description 1
- 206010058046 Post procedural complication Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000003906 hydrocephalus Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 201000009941 intracranial hypertension Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Images
Landscapes
- External Artificial Organs (AREA)
Abstract
本实用新型涉及一种脑室‑腹腔脑脊液分流管分流量检测装置,该检测装置括一储液囊,储液囊的背部为具有一定厚度的硬质医用材料,储液囊前部为软质医用材料,储液囊上端和下端各自设置有进液口和出液口,进液口、出液口分别包裹有进液管和出液管,且进液口和进液管之间密封无渗液,出液口和出液管之间密封无渗液;储液囊前部的中间部位或中上部设置有耐穿刺且穿刺孔可以自动闭合的穿刺部。本实用新型可以在不影响引流的情况下检测脑室‑腹腔脑脊液分流管的分流量,给医生的诊断和治疗提供判断依据,通过分流量的检测及时调整患者分流管的压力,减少术后并发症,减轻患者痛苦,提高治疗效果。
The utility model relates to a ventricle-peritoneal cerebrospinal fluid shunt tube flow detection device. The detection device comprises a liquid storage bag, the back of the liquid storage bag is made of hard medical material with a certain thickness, and the front of the liquid storage bag is made of soft medical material. Material, the upper end and the lower end of the liquid storage bag are respectively provided with a liquid inlet and a liquid outlet, the liquid inlet and the liquid outlet are respectively wrapped with a liquid inlet pipe and a liquid outlet pipe, and the liquid inlet and the liquid inlet pipe are sealed without leakage. There is no leakage between the liquid outlet and the liquid outlet pipe; the middle part or the upper middle part of the front part of the liquid storage bag is provided with a puncture-resistant puncture part that can automatically close the puncture hole. The utility model can detect the shunt flow of the ventricle-peritoneal cerebrospinal fluid shunt without affecting the drainage, provides a judgment basis for the diagnosis and treatment of doctors, adjusts the pressure of the shunt tube of the patient in time through the detection of the shunt flow, and reduces postoperative complications , alleviate the pain of patients and improve the treatment effect.
Description
技术领域technical field
本实用新型涉及医疗器械领域,尤其是一种脑室-腹腔脑脊液分流管分流量检测装置。The utility model relates to the field of medical equipment, in particular to a ventricle-peritoneal cerebrospinal fluid shunt pipe shunt flow detection device.
背景技术Background technique
脑室-腹腔分流术是治疗脑积水最常用的方法,分流术需要将脑脊液由脑室端引流到腹腔经腹腔吸收。脑室的压力、脑脊液的分泌量、脑脊液的吸收情况、腹腔压力、所使用的分流装置等因素均会影响分流量。分流量过多可导致裂隙样脑室和低颅压,分流不足时又会引起颅内高压症状。分流装置梗阻也是术后常见的并发症。目前分流量主要依赖分流装置上的阀门进行压力控制,其原理是当脑室内压力高于阀门压力时,脑脊液流向腹腔。部分阀门可以根据术后临床表现调整压力。但在临床实践中,由于患者体位的变化产生虹吸效应等情况,脑脊液的流量并不能完全由分流阀控制,造成分流量不确定。检测脑脊液的分流量对分流术后分流阀门的调整、术后并发症的检测以及临床研究具有重要意义,但目前国内外均无脑脊液分流量的检测设备。Ventricular-peritoneal shunt is the most commonly used method for the treatment of hydrocephalus. The shunt needs to drain the cerebrospinal fluid from the ventricle end to the abdominal cavity for absorption through the abdominal cavity. Ventricular pressure, cerebrospinal fluid secretion, absorption of cerebrospinal fluid, intra-abdominal pressure, and the shunt device used will all affect the shunt flow. Excessive shunt flow can lead to fissure-like ventricles and low intracranial pressure, and insufficient shunt can cause symptoms of intracranial hypertension. Shunt device obstruction is also a common postoperative complication. At present, the shunt flow mainly relies on the valve on the shunt device for pressure control. The principle is that when the pressure in the ventricle is higher than the valve pressure, the cerebrospinal fluid flows to the abdominal cavity. Some valves can adjust the pressure according to postoperative clinical manifestations. However, in clinical practice, the flow of cerebrospinal fluid cannot be completely controlled by the shunt valve due to the siphon effect caused by the change of the patient's body position, resulting in an uncertain shunt flow. The detection of the shunt flow of CSF is of great significance for the adjustment of the shunt valve after shunt surgery, the detection of postoperative complications, and clinical research.
发明内容SUMMARY OF THE INVENTION
针对上述缺陷,本实用新型提供一种脑室-腹腔脑脊液分流管分流量检测装置,可以在不影响引流的情况下,检测脑室-腹腔分流管的分流量,给医生的诊断和治疗提供判断依据,通过分流量的检测及时调整患者分流管的压力,减少术后并发症,减轻患者痛苦,提高治疗效果。In view of the above defects, the present utility model provides a ventriculo-peritoneal cerebrospinal fluid shunt shunt flow detection device, which can detect the shunt flow of the ventricle-peritoneal shunt tube without affecting the drainage, so as to provide a judgment basis for the diagnosis and treatment of doctors, Through the detection of the shunt flow, the pressure of the patient's shunt can be adjusted in time, so as to reduce postoperative complications, relieve the pain of the patient, and improve the treatment effect.
本实用新型的目的及解决其技术问题是采用以下技术方案来实现的。依据本实用新型提出的一种脑室-腹腔脑脊液分流管分流量检测装置,包括一储液囊,储液囊的背部为具有一定厚度的硬质医用材料,储液囊前部为软质医用材料,储液囊上端和下端各自设置有进液口和出液口,进液口、出液口分别包裹有进液管和出液管,且进液口和进液管之间密封无渗液,出液口和出液管之间密封无渗液;储液囊前部的中间部位或中上部设置有耐穿刺且穿刺孔可以自动闭合的穿刺部。The purpose of the present utility model and the solution to its technical problems are achieved by adopting the following technical solutions. A ventriculo-peritoneal cerebrospinal fluid shunt pipe shunt flow detection device proposed according to the utility model includes a liquid storage bag, the back of the liquid storage bag is made of hard medical material with a certain thickness, and the front of the liquid storage bag is made of soft medical material The upper end and the lower end of the liquid storage bag are respectively provided with a liquid inlet and a liquid outlet, the liquid inlet and the liquid outlet are respectively wrapped with a liquid inlet pipe and a liquid outlet pipe, and the liquid inlet and the liquid inlet pipe are sealed without seepage The liquid outlet and the liquid outlet pipe are sealed without leakage; the middle part or the upper middle part of the front part of the liquid storage bag is provided with a puncture-resistant part that can automatically close the puncture hole.
进一步地,所述储液囊的容纳体积为3-10ml,穿刺部底面圆直径d为0.7-1.5cm,穿刺部的厚度为1-3mm,储液囊背部的厚度为1-2mm。Further, the storage volume of the liquid storage bag is 3-10ml, the diameter d of the bottom surface of the puncture part is 0.7-1.5cm, the thickness of the puncture part is 1-3mm, and the thickness of the back of the liquid storage bag is 1-2mm.
更进一步地,所述储液囊的体积为5ml,穿刺部底面圆直径d为1cm,穿刺部的厚度为2mm,储液囊背部的厚度为2mm。Further, the volume of the liquid storage bag is 5ml, the diameter d of the bottom surface of the puncture part is 1cm, the thickness of the puncture part is 2mm, and the thickness of the back of the liquid storage bag is 2mm.
进一步地,所述进液管和出液管上各自分出有多个分支管路,每个分支管路上均设置有多个均匀或不均匀排列的侧孔。Further, the liquid inlet pipe and the liquid outlet pipe are respectively divided into a plurality of branch pipelines, and each branch pipeline is provided with a plurality of uniform or non-uniformly arranged side holes.
进一步地,所述穿刺部较储液囊前部凸出。Further, the puncture part is protruded from the front part of the liquid storage bag.
进一步地,所述穿刺部外周还设置有一圈不透X光的感应元件。Further, a circle of X-ray-tight inductive elements is also arranged on the outer periphery of the puncturing portion.
进一步地,所述感应元件的材质为铁、铅、金、铂中的一种。Further, the material of the sensing element is one of iron, lead, gold, and platinum.
进一步地,所述进液管和出液管上均设置有用于提高脑脊液分流管与进液管和出液管连接可靠性及密封性的凸起部件。Further, both the liquid inlet pipe and the liquid outlet pipe are provided with raised parts for improving the connection reliability and tightness of the cerebrospinal fluid shunt pipe and the liquid inlet pipe and the liquid outlet pipe.
本实用新型具有以下有益效果:The utility model has the following beneficial effects:
本实用新型结构简单,体积小,可以在不影响引流的情况下,随时检测脑室-腹腔分流管的分流量,给医生的诊断和治疗提供判断依据,通过分流量的检测及时调整患者分流管的压力,减少术后并发症,减轻患者痛苦,提高治疗效果。所用检测方法为向储液囊中注射0.5ml 10mg/ml的丙戊酸钠溶液,丙戊酸钠一次的总用量为5mg,且丙戊酸钠水溶解性好,检测方便,许多医院有检测条件,费用不高,关键是对人体无害,为检测脑脊液分流量带来极大的方便。The utility model is simple in structure and small in volume, can detect the shunt flow of the ventricle-peritoneal shunt tube at any time without affecting the drainage, provides a judgment basis for the diagnosis and treatment of doctors, and adjusts the flow rate of the shunt tube of the patient in time through the detection of the shunt flow. pressure, reduce postoperative complications, relieve patient pain, and improve treatment effect. The detection method used is to inject 0.5ml of 10mg/ml sodium valproate solution into the storage bag, the total amount of sodium valproate at one time is 5mg, and the water solubility of sodium valproate is good, and the detection is convenient. Many hospitals have detection methods. The condition is not high, the cost is not high, and the key is that it is harmless to the human body, which brings great convenience to the detection of cerebrospinal fluid shunt flow.
附图说明Description of drawings
图1是本实用新型与现有的分流管和分流阀门配套使用时的示意图;Fig. 1 is the schematic diagram when the utility model is used together with existing shunt pipe and shunt valve;
图2是本实用新型示例一的主视图;Fig. 2 is the front view of example one of the present utility model;
图3是图2的右视图;Fig. 3 is the right side view of Fig. 2;
图4是本实用新型示例二的主视图;Fig. 4 is the front view of the second example of the present utility model;
图5是图4的右视图。FIG. 5 is a right side view of FIG. 4 .
1:储液囊,1-1:储液囊背部,1-2储液囊前部,2:进液管,3:出液管,1: Reservoir, 1-1: Back of Reservoir, 1-2 Front of Reservoir, 2: Inlet tube, 3: Outlet tube,
4:穿刺部,5:分流阀门,6:上半部分分流管,7:下半部分分流管,4: puncture part, 5: shunt valve, 6: upper half shunt tube, 7: lower half shunt tube,
8:感应元件,9:感应囊,10:分支管路,11:侧孔,12:凸起部件,8: Sensing element, 9: Sensing bag, 10: Branch pipe, 11: Side hole, 12: Raised part,
13:插合引导面,14:上半部分分流管端口15:固定孔13: Insertion guide surface, 14: Upper half shunt port 15: Fixing hole
具体实施方式Detailed ways
为更进一步阐述本实用新型为达成预定发明目的所采取的技术手段及功效,以下结合附图及较佳实施例,对依据本实用新型提出的一种脑室-腹腔脑脊液分流管分流量检测装置进行详细说明。In order to further illustrate the technical means and effects adopted by the present invention to achieve the predetermined purpose of the invention, the following in conjunction with the accompanying drawings and preferred embodiments, a ventriculo-peritoneal cerebrospinal fluid shunt flow detection device proposed by the present invention is carried out. Detailed description.
本实用新型的脑室-腹腔脑脊液分流管分流量检测装置包括一储液囊1,储液囊背部1-1是具有一定厚度的硬质医用材料,不容易被针刺破且对人体无害,不会引起人体不适。储液囊前部1-2为软质医用材料也对人体无害,不会引起人体不适,其柔软程度和材质比如可以是现用输液软管的柔软度和材质。储液囊前部的投影面积应略小于背部的面积,如图2所示。储液囊上、下端各自设置有进液口和出液口,进液口、出液口分别包裹有进液管2和出液管3,且进液口和进液管之间密封无渗漏,出液口和出液管之间密封无渗漏。储液囊前部中间部位(如图2和图3所示)或中上部(如图4和图5所示)设置有穿刺部4,穿刺部的材质可以是硅橡胶材料,穿刺部耐穿刺,且穿刺针拔出后,穿刺部材料可以自动闭合并可以防止储液囊中的液体渗出。The ventriculo-peritoneal cerebrospinal fluid shunt pipe shunt flow detection device of the present invention comprises a
本实用新型用于和现有的脑脊液分流管及与分流管适配的分流阀门配套使用,如图1所示,脑脊液分流术中,分流管上端置于患者脑室内,下端置于患者腹部内,通过分流管将患者脑室的脑脊液引流至腹腔经患者身体吸收,现有技术中,分流管靠近上端处装有一分流阀门5,该分流阀门通常埋置在患者耳后皮下,脑脊液分流量的大小通过分流阀门调整。一般一个脑脊液患者一天分流量在200-300ml是比较理想的状况,但是,目前分流量大小调整并没有任何检测装置或方法,全凭患者或医护人员感觉,造成分流量大小调整不准确,容易使患者产生术后并发症等状况。本实用新型与分流管和分流阀门配套使用时,将本实用新型的装置埋置在患者胸部皮下,将原有的分流管相应位置剪开,剪开处上半部分分流管6与本实用新型装置的进液管插接连通,剪开处下半部分分流管7与本实用新型装置的出液管插接连通,如图1所示。整个分流管埋置在人体中,一端连接脑室,一端连接腹腔,分流阀门埋置在耳后皮下,本实用新型的检测装置埋置在胸部皮下(需做手术埋置,但该埋置术为医学界常规手术)。The utility model is used for matching with the existing cerebrospinal fluid shunt tube and the shunt valve matched with the shunt tube. As shown in Figure 1, in the cerebrospinal fluid shunt operation, the upper end of the shunt tube is placed in the patient's ventricle, and the lower end is placed in the patient's abdomen. , the cerebrospinal fluid of the patient's ventricle is drained to the abdominal cavity through the shunt tube to be absorbed by the patient's body. In the prior art, the shunt tube is equipped with a
利用本实用新型装置检测分流量的方法为:用注射针通过人体胸部皮肤刺入穿刺部往储液囊里面打入0.5ml 10mg/ml的丙戊酸钠溶液,记下打入丙戊酸钠溶液后的时间t1,该t1时刻储液囊中丙戊酸钠的初始浓度C1=(0.5ml×10mg/ml)/V0,其中V0是储液囊的体积,单位:ml。由于脑脊液不断流动,部分丙戊酸钠随脑脊液排出到腹腔中,因此,随着时间增加,储液囊中的丙戊酸钠浓度逐渐降低。等到时间t2时,用注射针通过人体胸部皮肤刺入穿刺部将储液囊中的液体抽出0.5ml,检测t2时抽出的0.5ml溶液中丙戊酸钠的浓度C2,根据公式V1=-V0×ln(C2/C1)计算出(t2-t1)时间段内的分流量V1。其中,V0是指储液囊的体积,单位:ml,C1是t1时刻储液囊中丙戊酸钠的初始浓度,单位:mg/ml,C2是t2时刻抽出的0.5ml溶液中丙戊酸钠的测试浓度,单位:mg/ml。将V1换算成24小时流量V24,与一天24小时理想流量为200-300ml进行比较。如果比较结果V24过大或者过小,则控制分流阀门对分流管的分流量进行调整。The method of using the device of the utility model to detect the shunt flow is as follows: use an injection needle to pierce the puncture part through the skin of the human chest and inject 0.5ml of 10mg/ml sodium valproate solution into the liquid storage bag, and record the injection of sodium valproate. At time t 1 after the solution, the initial concentration of sodium valproate in the storage bag at t 1 is C 1 =(0.5ml×10mg/ml)/V 0 , where V 0 is the volume of the storage bag, unit: ml . Due to the continuous flow of cerebrospinal fluid, part of the sodium valproate is excreted into the abdominal cavity with the cerebrospinal fluid, so the concentration of sodium valproate in the reservoir gradually decreases with time. Wait until time t2 , use an injection needle to pierce the puncture part through the human chest skin to extract 0.5ml of the liquid in the storage bag, and detect the concentration C2 of sodium valproate in the 0.5ml solution extracted at t2 , according to formula V 1 = -V 0 ×ln(C 2 /C 1 ) calculates the divided flow rate V 1 in the time period of (t 2 -t 1 ). Among them, V 0 refers to the volume of the storage bag, unit: ml, C 1 is the initial concentration of sodium valproate in the storage bag at time t 1 , unit: mg/ml, C 2 is 0.5ml drawn out at time t 2 Test concentration of sodium valproate in solution, unit: mg/ml. Convert V 1 into a 24-hour flow V 24 and compare it with an ideal flow of 200-300ml for 24 hours a day. If the comparison result V 24 is too large or too small, the shunt valve is controlled to adjust the shunt flow of the shunt pipe.
以上所述方法中,由于储液囊需要埋置在人体内,体积过大会对患者损伤大,使人体不适,体积过小造成检测误差大,因此,本实用新型的储液囊体积V0设计为3-10ml比较好,经过反复的体外实验,储液囊体积V0优选为5ml,此时误差已经很小。In the above-mentioned method, since the liquid storage bag needs to be embedded in the human body, if the volume is too large, it will cause great damage to the patient and make the human body uncomfortable, and if the volume is too small, the detection error will be large. It is better to be 3-10ml. After repeated in vitro experiments, the volume V 0 of the liquid storage bag is preferably 5ml, and the error is already small at this time.
由于丙戊酸钠水溶解性好,检测方便(许多医院有检测丙戊酸钠的设备),费用不高,关键是对人体无害,综合多种物质实验结果,最终选定丙戊酸钠作为检测物质。且0.5ml10mg/ml的丙戊酸钠溶液中丙戊酸钠的质量为5mg,量非常小,对人体完全无害。Due to the good solubility of sodium valproate in water, the detection is convenient (many hospitals have equipment for detecting sodium valproate), and the cost is not high. as the detection substance. And the mass of sodium valproate in 0.5ml 10mg/ml sodium valproate solution is 5mg, the amount is very small and completely harmless to human body.
同样地,由于储液囊需要埋置在人体内,为了方便医护人员准确刺入穿刺部,将穿刺部设计为凸起结构,如图3和图5所示,穿刺部较储液囊前部凸起,方便医护人员通过手触感知到穿刺部的位置进行穿刺。穿刺部底面圆直径d可以是0.7-1.5cm,优选1cm。Similarly, since the liquid storage bag needs to be embedded in the human body, in order to facilitate the medical staff to accurately pierce the puncture part, the puncture part is designed as a convex structure, as shown in Figures 3 and 5, the puncture part is more Protruding, it is convenient for medical staff to sense the position of the puncture part by hand to perform puncture. The diameter d of the bottom surface of the puncture portion may be 0.7-1.5 cm, preferably 1 cm.
进一步地,可以在穿刺部外周设置一圈不透X光的球形或半球形或椭圆形的感应元件8,如果在体外无法通过手触感知确认穿刺点注射丙戊酸钠溶液时,可以借助X光检测判定穿刺部的位置进行精准穿刺。感应元件可以是铁、铅、金、铂等不透X光的材料。感应元件可以是封装在感应囊9中,感应囊外表面的材质为软质医用材料且不会引起人体不适,对人体无害。感应囊外表面材质与储液囊前部材质可以相同,也可以不同。Further, a circle of spherical or hemispherical or
进一步地,穿刺部可以具有一定厚度,比如1-3mm厚,采用硅橡胶材料,注射针穿刺并拔出后,穿刺孔可以自动闭合,防止储液囊里的液体渗出。为了保证穿刺部的耐穿刺性能,以及为了减小注射误差,注射器最好采用细针头,可以是规格为1ml或2ml的注射器(针头规格分别是0.45mm或0.5/0.6mm)。为了避免穿刺时将储液囊背部刺破,储液囊背部采用具有一定厚度的硬质医用材料,比如可以是高分子量聚乙烯材料。注射针不会轻易将储液囊背部刺破。储液囊背部厚度可以是1-2mm,且储液囊背部边角圆润光滑,埋置在人体皮下不会造成不适。Further, the puncture portion may have a certain thickness, such as 1-3 mm thick, and is made of silicone rubber. After the injection needle is punctured and pulled out, the puncture hole can be automatically closed to prevent the liquid in the liquid storage bag from leaking out. In order to ensure the puncture resistance of the puncture part and reduce the injection error, the syringe preferably adopts a thin needle, which can be a 1ml or 2ml syringe (needle specifications are 0.45mm or 0.5/0.6mm respectively). In order to avoid puncturing the back of the liquid storage bag during puncturing, the back of the liquid storage bag is made of a rigid medical material with a certain thickness, such as a high molecular weight polyethylene material. The needle will not easily puncture the back of the reservoir. The thickness of the back of the liquid storage bag can be 1-2 mm, and the corners of the back of the liquid storage bag are round and smooth, and it will not cause discomfort when embedded under the human skin.
为了保证丙戊酸钠溶液注射进储液囊之后在储液囊中快速分布均匀,减小测定误差,将进液管和出液管设置为树状结构,如图2和图4所示,进液管和出液管上各自分出多个分支管路10,且每个分支管路上均设置有多个侧孔11,侧孔可以是有序排列也可以是无规则排布在分支管路上,脑脊液不仅从分支管路的进、出口进液或出液,也从侧孔中进液或出液,当丙戊酸钠溶液注射进去之后,该结构可以加快储液囊中液体流动,对丙戊酸钠在储液囊中快速分布均匀具有一定的促进作用。图1-图5所示侧孔均匀排布,每个分支管路上沿圆周可以排布2列-6列侧孔,优选4列。In order to ensure that the sodium valproate solution is quickly and evenly distributed in the liquid storage bag after being injected into the liquid storage bag, and reduces the measurement error, the liquid inlet pipe and the liquid outlet pipe are set to a tree-like structure, as shown in Figure 2 and Figure 4, The liquid inlet pipe and the liquid outlet pipe are respectively divided into a plurality of
优选地,为了进一步加快丙戊酸钠溶液在储液囊中分布均匀,注射针穿刺时可以选择穿刺部略向上方的部位为穿刺点,也可以将穿刺部设置在储液囊上部,如图4和图5所示。Preferably, in order to further speed up the uniform distribution of the sodium valproate solution in the liquid storage bag, when the injection needle is punctured, the puncture part can be selected as the puncture point slightly upward, or the puncture part can be set on the upper part of the liquid storage bag, as shown in the figure 4 and Figure 5.
为了提高分流管与进液管和出液管连接的可靠性及密封性,本实用新型的进液管和出液管上均设置有球形的凸起部件12,以图2的进液管为例,将进液管插入分流管,使上半部分分流管端口14位于进液管上球形凸起部件的下方,插好之后,分流管不易从进液管上脱落。为了插管时更容易,将进液管入口处设置一斜面作为插合引导面13,插合引导面从进液管入口处延伸至凸起部件方便插管操作。出液管的结构和进液管相同,也设置有对应的凸起部件和插合引导面,如图2所示。In order to improve the reliability and tightness of the connection between the shunt pipe and the liquid inlet pipe and the liquid outlet pipe, the liquid inlet pipe and the liquid outlet pipe of the present invention are provided with spherical convex parts 12, and the liquid inlet pipe in FIG. 2 is For example, insert the liquid inlet pipe into the shunt pipe, so that the upper part of the
进一步地,进液管和出液管也可以分别设置在储液囊侧面的上部或者下部,其位置不限定,优选为分别设置在储液囊的上、下端。进液管、出液管与储液囊前部和背部材料在制作时一体压制成型,保证进液管、出液管与储液囊连接处的密封性能,不渗液,整个储液囊密封良好,使用时不渗液。储液囊背部的四角还设置有固定孔15用于将本实用新型固定在人体内。Further, the liquid inlet pipe and the liquid outlet pipe can also be respectively arranged at the upper or lower part of the side surface of the liquid storage bag, and their positions are not limited, but are preferably respectively arranged at the upper and lower ends of the liquid storage bag. The liquid inlet pipe, the liquid outlet pipe and the front and back materials of the liquid storage bag are integrally pressed and formed during production to ensure the sealing performance of the connection between the liquid inlet pipe, the liquid outlet pipe and the liquid storage bag, no liquid leakage, and the entire liquid storage bag is sealed Good, not oozing when used. The four corners of the back of the liquid storage bag are also provided with fixing
进一步地,检测脑脊液流量时,时间段(t2-t1)可以是1-24小时。Further, when the cerebrospinal fluid flow is detected, the time period (t 2 -t 1 ) may be 1-24 hours.
实施例1:Example 1:
假定储液囊体积为V0=5ml,早上8点时刻往储液囊中打入0.5ml 10mg/ml的丙戊酸钠溶液,则丙戊酸钠打入后储液囊中丙戊酸钠的浓度为C1=(0.5ml×10mg/ml)/V0=(0.5ml×10mg/ml)/5ml=1mg/ml。上午9点时刻从储液囊中抽出0.5ml液体检测丙戊酸钠的浓度为C2=0.1mg/ml,则1小时(t2-t1=1h)内脑脊液分流量V1根据公式V1=-V0×ln(C2/C1)计算得为:V1=-5ml×ln(0.1mg/ml/1mg/ml)=11.5ml,将V1换算为24小时分流量为V24=11.5ml×24=276ml,一天24小时内脑脊液的理想分流量为200-300ml,V24与理想分流量相比为正常值,说明此时患者脑脊液分流量大小正常,不用调整分流量。Assuming that the volume of the storage bag is V 0 =5ml, 0.5ml of 10mg/ml sodium valproate solution is injected into the storage bag at 8:00 in the morning, then the sodium valproate in the storage bag after the sodium valproate is injected The concentration is C 1 =(0.5ml×10mg/ml)/V 0 =(0.5ml×10mg/ml)/5ml=1mg/ml. At 9:00 am, 0.5 ml of liquid was withdrawn from the reservoir to detect the concentration of sodium valproate as C 2 = 0.1 mg/ml, then the cerebrospinal fluid shunt flow V 1 within 1 hour (t 2 -t 1 = 1 h) was determined according to formula V 1 =-V 0 ×ln(C 2 /C 1 ) is calculated as: V 1 =-5ml×ln(0.1mg/ml/1mg/ml)=11.5ml, and V 1 is converted into a 24-hour divided flow rate as V 24 = 11.5ml × 24 = 276ml, the ideal shunt flow of cerebrospinal fluid in 24 hours a day is 200-300ml, and V 24 is a normal value compared with the ideal shunt flow, indicating that the patient's cerebrospinal fluid shunt volume is normal at this time, and there is no need to adjust the shunt flow.
实施例2:Example 2:
假定储液囊体积为V0=5ml,早上8点时刻往储液囊中打入0.5ml 10mg/ml的丙戊酸钠溶液,则丙戊酸钠打入后储液囊中丙戊酸钠的浓度为C1=(0.5ml×10mg/ml)/V0=(0.5ml×10mg/ml)/5ml=1mg/ml。上午9点时刻从储液囊中抽出0.5ml液体检测丙戊酸钠的浓度为C2=0.3mg/ml,则1小时(t2-t1=1h)内脑脊液分流量V1根据公式V1=-V0×ln(C2/C1)计算得为:V1=-5ml×ln(0.3mg/ml/1mg/ml)=6ml,将V1换算为24小时分流量为V24=6ml×24=144ml,一天24小时内脑脊液的理想分流量为200-300ml,V24与理想分流量相比过小,说明此时患者脑脊液分流量过小,此时通过控制分流阀门对分流管的分流量进行调整。Assuming that the volume of the storage bag is V 0 =5ml, 0.5ml of 10mg/ml sodium valproate solution is injected into the storage bag at 8:00 in the morning, then the sodium valproate in the storage bag after the sodium valproate is injected The concentration is C 1 =(0.5ml×10mg/ml)/V 0 =(0.5ml×10mg/ml)/5ml=1mg/ml. At 9:00 am, 0.5 ml of liquid was withdrawn from the reservoir to detect the concentration of sodium valproate as C 2 = 0.3 mg/ml, then the cerebrospinal fluid shunt flow V 1 within 1 hour (t 2 -t 1 = 1 h) was calculated according to formula V 1 =-V 0 ×ln(C 2 /C 1 ) is calculated as: V 1 =-5ml×ln(0.3mg/ml/1mg/ml)=6ml, and V 1 is converted into a 24-hour divided flow rate as V 24 =6ml×24=144ml, the ideal shunt flow of cerebrospinal fluid in 24 hours a day is 200-300ml, and V 24 is too small compared with the ideal shunt flow, indicating that the patient’s cerebrospinal fluid shunt flow is too small at this time, and the shunt is controlled by the shunt valve. The split flow of the tube is adjusted.
以上所述,仅是本实用新型的较佳实施例而已,并非对本实用新型做任何形式上的限制,任何熟悉本专业的技术人员,在不脱离本实用新型技术方案范围内,利用上述技术内容做出些许更动或修饰的实施例,均仍属于本实用新型技术方案的范围内。The above are only preferred embodiments of the present utility model, and are not intended to limit the present utility model in any form. Any person who is familiar with this profession, without departing from the scope of the technical solution of the present utility model, utilizes the above-mentioned technical content The embodiments with some changes or modifications still fall within the scope of the technical solution of the present invention.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201921350762.9U CN210811025U (en) | 2019-08-19 | 2019-08-19 | A ventriculo-peritoneal cerebrospinal fluid shunt flow detection device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201921350762.9U CN210811025U (en) | 2019-08-19 | 2019-08-19 | A ventriculo-peritoneal cerebrospinal fluid shunt flow detection device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN210811025U true CN210811025U (en) | 2020-06-23 |
Family
ID=71272396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201921350762.9U Expired - Fee Related CN210811025U (en) | 2019-08-19 | 2019-08-19 | A ventriculo-peritoneal cerebrospinal fluid shunt flow detection device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN210811025U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116077806A (en) * | 2023-01-19 | 2023-05-09 | 深圳湃诺瓦医疗科技有限公司 | Cerebrospinal fluid shunt system and its control method, control device and storage medium |
-
2019
- 2019-08-19 CN CN201921350762.9U patent/CN210811025U/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116077806A (en) * | 2023-01-19 | 2023-05-09 | 深圳湃诺瓦医疗科技有限公司 | Cerebrospinal fluid shunt system and its control method, control device and storage medium |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2355476T3 (en) | APPARATUS FOR MONITORING INTRA-ABDOMINAL PRESSURE. | |
| CN206508308U (en) | A kind of abdominal pressure measurement apparatus with urethral catheterization function | |
| CN206026751U (en) | Built -in colporrhagia negative pressure drainage metering device of obstetrical department | |
| CN102389346B (en) | Bladder stoma without urine collecting bag | |
| CN203970988U (en) | A kind of ventricles of the brain-abdominal cavity shunt device of cerebrospinal fluid | |
| CN209575352U (en) | A kind of drainage of cerebrospinal fluid device | |
| CN210811025U (en) | A ventriculo-peritoneal cerebrospinal fluid shunt flow detection device | |
| CN207871259U (en) | Disposable sterilized catheter | |
| CN206315095U (en) | Cystometry device | |
| CN206463266U (en) | A kind of urological department urethral catheterization device | |
| CN110338779B (en) | Ventricular-abdominal cavity cerebrospinal fluid shunt tube flow dividing amount detection device and detection method | |
| CN204319489U (en) | Anastomotic stoma conduit after operation on rectum | |
| CN109939330A (en) | A one-time use of sterile silicone water bladder cystostomy tube | |
| CN211486133U (en) | A urinary catheter with a pressure sensor | |
| CN205683326U (en) | A kind of measurable Novel urinary catheterization device of seriality pressure | |
| CN211066666U (en) | Simple bladder capacity and pressure measuring device | |
| CN204910455U (en) | Medical multicavity associated drainage catheter | |
| CN106975143A (en) | Can pressure measuring alarm bladder stoma drainage system | |
| CN204193267U (en) | A kind of disposable cerebrospinal fluid pressure measurement, drainage tube | |
| CN211214891U (en) | A portable multifunctional indwelling urinary catheter | |
| CN205215917U (en) | Ventricles of brain venous sinus diverging device | |
| CN210903056U (en) | Closed manual pressure measuring device | |
| CN213696893U (en) | Medical multi-functional water column pressure measurement device | |
| CN204192605U (en) | A kind of disposable two-chamber cerebrospinal fluid pressure measurement, drainage tube | |
| CN211050758U (en) | A bladder filling balancer used in pelvic tumor radiotherapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200623 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
